Kymera Therapeutics Inc (KYMR) Insider Trading
- $64,580,508.56
- $131,553,155.40
- March 3, 2025
- Nello Mainolfi
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 3, 2025 | CFO | 7,035 | $30.45 | Sell | $214,215.75 | |
March 3, 2025 | COO | 1,383 | $30.45 | Sell | $42,112.35 | |
March 3, 2025 | Insider | 2,241 | $30.45 | Sell | $68,238.45 | |
Jan. 6, 2025 | Insider | 3,129 | $41.75 | Sell | $130,635.75 | |
Sept. 17, 2024 | Director | 13,500 | $48.28 | Sell | $651,780.00 | |
Aug. 26, 2024 | Director | 5,000 | $49.10 | Sell | $245,500.00 | |
July 16, 2024 | Insider | 23,145 | $45.81 | Sell | $1,060,272.45 | |
July 9, 2024 | Director | 453,960 | $38.21 | Sell | $17,345,811.60 | |
June 12, 2024 | Director | 16,740 | $35.45 | Sell | $593,433.00 | |
June 7, 2024 | Director | 8,500 | $32.99 | Sell | $280,415.00 | |
March 15, 2024 | Director | 71,764 | $40.46 | Sell | $2,903,571.44 | |
March 13, 2024 | Major Shareholder | 115,090 | $42.23 | Sell | $4,860,250.70 | |
March 13, 2024 | Director | 139,255 | $42.23 | Sell | $5,880,738.65 | |
March 11, 2024 | Director | 51,184 | $42.85 | Sell | $2,193,234.40 | |
March 11, 2024 | Major Shareholder | 42,302 | $42.85 | Sell | $1,812,640.70 | |
March 4, 2024 | CFO | 3,934 | $41.86 | Sell | $164,677.24 | |
Feb. 21, 2024 | Director | 4,385 | $39.05 | Sell | $171,234.25 | |
Feb. 9, 2024 | Insider | 46,137 | $35.50 | Sell | $1,637,863.50 | |
Jan. 23, 2024 | Director | 10,000 | $30.05 | Sell | $300,500.00 | |
Jan. 4, 2024 | Insider | 3,295 | $22.58 | Sell | $74,401.10 | |
Nov. 2, 2023 | Director | 216,406 | $11.64 | Buy | $2,518,965.84 | |
March 2, 2023 | CFO | 1,370 | $31.00 | Sell | $42,470.00 | |
Jan. 11, 2023 | Director | 22,110 | $29.89 | Buy | $660,867.90 | |
Jan. 11, 2023 | Major Shareholder | 21,683 | $29.96 | Sell | $649,622.68 | |
Dec. 14, 2022 | Director | 378,966 | $31.37 | Sell | $11,888,163.42 | |
Dec. 14, 2022 | Major Shareholder | 296,077 | $31.37 | Sell | $9,287,935.49 | |
Nov. 2, 2022 | Director | 123,619 | $30.02 | Sell | $3,711,042.38 | |
Nov. 2, 2022 | Major Shareholder | 96,581 | $30.02 | Sell | $2,899,361.62 | |
Oct. 31, 2022 | Director | 120,622 | $30.23 | Sell | $3,646,403.06 | |
Oct. 31, 2022 | Major Shareholder | 94,239 | $30.23 | Sell | $2,848,844.97 | |
Oct. 28, 2022 | Major Shareholder | 71,135 | $30.00 | Sell | $2,134,050.00 | |
Oct. 28, 2022 | Director | 91,050 | $30.00 | Sell | $2,731,500.00 | |
Aug. 22, 2022 | Director | 545,525 | $26.00 | Buy | $14,183,650.00 | |
May 26, 2022 | Director | 224,057 | $14.21 | Buy | $3,183,849.97 | |
May 20, 2022 | Director | 10,100 | $14.00 | Buy | $141,400.00 | |
May 5, 2022 | Director | 150,000 | $19.60 | Buy | $2,940,000.00 | |
Jan. 31, 2022 | Director | 34,408 | $40.70 | Buy | $1,400,405.60 | |
Jan. 27, 2022 | Director | 95,901 | $38.33 | Buy | $3,675,885.33 | |
Jan. 24, 2022 | Director | 272,767 | $37.76 | Buy | $10,299,681.92 | |
Jan. 12, 2022 | CFO | 15,000 | $51.85 | Sell | $777,750.00 | |
Jan. 12, 2022 | CEO | 8,612 | $52.08 | Sell | $448,512.96 | |
Jan. 10, 2022 | CEO | 22,465 | $53.26 | Sell | $1,196,485.90 | |
Dec. 3, 2021 | CFO | 10,000 | $53.56 | Sell | $535,600.00 | |
Nov. 2, 2021 | Insider | 14,996 | $63.22 | Sell | $948,047.12 | |
Oct. 11, 2021 | CEO | 6,456 | $53.68 | Sell | $346,558.08 | |
Oct. 8, 2021 | CEO | 41,544 | $56.76 | Sell | $2,358,037.44 | |
Sept. 3, 2021 | CFO | 10,000 | $60.12 | Sell | $601,200.00 | |
Aug. 27, 2021 | Insider | 33,779 | $60.12 | Sell | $2,030,793.48 | |
Aug. 17, 2021 | Insider | 54,000 | $50.37 | Sell | $2,719,980.00 | |
Aug. 11, 2021 | Director | 242,133 | $61.00 | Sell | $14,770,113.00 |
Insiders are both buying and selling Kymera Therapeutics Inc stock.
The insider traders at Kymera Therapeutics Inc are: Nello Mainolfi, Bruce Booth, Bvf Partners L P/Il, Bruce N Jacobs, Venture Fund X L.P. Atlas, Jared Gollob, Ellen Chiniara, Jeffrey W. Albers, Richard Chesworth, Joanna Horobin, Bruce N. Jacobs, Pamela Esposito, and Jeremy G Chadwick
The most active insider trader at Kymera Therapeutics Inc is Nello Mainolfi with 19 trades.
Bruce Booth has sold the most Kymera Therapeutics Inc stock with a total value of $95,968,097.55.
Bvf Partners L P/Il has bought the most Kymera Therapeutics Inc stock with a total value of $67,099,474.40.
The most recent insider trade for Kymera Therapeutics Inc was on March 3, 2025.
The single biggest insider buy for Kymera Therapeutics Inc was from Bvf Partners L P/Il with a total value of $25,575,802.00 on July 1, 2021.
The single biggest insider sell for Kymera Therapeutics Inc was from Bruce Booth with a total value of $17,345,811.60 on July 9, 2024.